Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, No. 246 Xuefu Road, Nangang DistrictHeilongjiang Province, Harbin, 150001, China.
The Key Laboratory of Myocardial Ischemia, Ministry of Education, Harbin, China.
Cell Commun Signal. 2023 Jul 21;21(1):176. doi: 10.1186/s12964-023-01196-z.
Although antiangiogenic therapy has been used in gastric cancer, disease progression due to drug resistance remains common. Neutrophils play an important role in the occurrence and progression of cancer via neutrophil extracellular traps (NETs). However, few studies have investigated angiogenic regulation in gastric cancer. We aimed to determine the role of NETs in promoting angiogenesis in gastric cancer. Multiple immunohistochemical staining was used to analyze the spatial distribution of NETs and microvessels in patient tissue samples. A mouse subcutaneous tumor model was established to determine the effect of NETs on tumor growth, and changes in microvessel density were observed via immunohistochemical staining. We screened differentially expressed proteins in HUVECs stimulated by NETs via proteomics. Cell Counting Kit-8, EdU labeling, and tubule formation assays were used to verify the effect of NETs on HUVEC proliferation, migration, and tubule formation. Blocking NETs, which was related to decreased microvessel density, significantly inhibited tumor growth in the murine subcutaneous tumor model. Compared with those of the control group, tumor volume and mass among mice in the inhibition group decreased by 61.3% and 77.9%, respectively. The NET-DNA receptor CCDC25 was expressed in HUVECs, providing a platform for NETs to promote HUVEC proliferation, migration, and tubulation. In an in vitro rat aortic explant model, NETs induced HUVEC proliferation, survival, and chemotaxis, which were not significantly different from those observed in the VEGF stimulation group. Our results confirm that NETs promote angiogenesis in gastric cancer, providing a theoretical basis for identifying new anti-vascular therapeutic targets. Video Abstract.
尽管抗血管生成治疗已在胃癌中得到应用,但由于耐药性导致的疾病进展仍然很常见。中性粒细胞通过中性粒细胞胞外诱捕网(NETs)在癌症的发生和发展中发挥重要作用。然而,很少有研究调查过胃癌中的血管生成调节。我们旨在确定 NETs 在促进胃癌血管生成中的作用。采用多重免疫组织化学染色分析患者组织样本中 NETs 和微血管的空间分布。建立小鼠皮下肿瘤模型,以确定 NETs 对肿瘤生长的影响,并通过免疫组织化学染色观察微血管密度的变化。通过蛋白质组学筛选 NETs 刺激的 HUVECs 中差异表达的蛋白质。细胞计数试剂盒-8、EdU 标记和管形成测定用于验证 NETs 对 HUVEC 增殖、迁移和管形成的影响。阻断 NETs 可降低微血管密度,显著抑制小鼠皮下肿瘤模型中的肿瘤生长。与对照组相比,抑制组中小鼠的肿瘤体积和质量分别减少了 61.3%和 77.9%。NET-DNA 受体 CCDC25 在 HUVECs 中表达,为 NETs 促进 HUVEC 增殖、迁移和管形成提供了平台。在体外大鼠主动脉外植体模型中,NETs 诱导 HUVEC 增殖、存活和趋化性,与 VEGF 刺激组观察到的结果没有显著差异。我们的研究结果证实了 NETs 促进胃癌中的血管生成,为确定新的抗血管治疗靶点提供了理论依据。视频摘要。